Amplycell

31/05/2018

President Trump on Wednesday signed legislation into law that gives patients the “right to try” experimental drugs, cementing a major policy priority for the White House.

01/04/2018

Fujifilm has acquired Irvine Scientific, adding a range of cell culture media to its growing bioprocessing business.

20/03/2018

Research & Development & Commercialization, this is the challenge to adress... At the quickest!

The R&D playbook is evolving as the industry looks to break down the silos between clinical and commercial operations – bringing commercial voices to the earliest phases of asset development.

20/03/2018

CDMOs continue to take on a larger role supporting sponsors in the pharmaceutical industry, though new technology and changing requirements could shift the models in which they operate.

13/02/2018

... And we have all those ingredients at AmplyCell!

Unrivalled data science expertise, evidence-based consulting and independent advice across the pharmaceutical R&D value chain

01/02/2018

New impressive labs close to Liège!

À l’abandon depuis plus de cinq ans, le site de Colgate-Palmolive renaît de ses cendres. Racheté en 2015, il accueille désormais, notamment, un laboratoire de 800 m². De quoi permettre aux sociétés pharmaceutiques et biotechnologiques de développer leurs produits en évitant le risque fina...

23/01/2018

Univercells keeps on going forward to reach it's mission... Biologics affordable to all!

La biotech carolo va recevoir 2,4 millions d'euros de la part de la Région wallonne pour développer une nouvelle plateforme de production d'anticorps. Avec ce financement, Univercells promet de déployer des unités de production à bas prix partout dans le monde.

19/10/2017

Nice results for Tocilizumab!

In patients with and suboptimal response to conventional synthetic , the initiation of tocilizumab appears to yield greater effectiveness and drug survival vs. the introduction tumor necrosis factor inhibitors, according to findings from the ACT-ion study.

17/10/2017

Plan as early as possible.

Gene therapy developers should start planning earlier, as EU GMO regulations are delaying clinical trial start-up across the bloc, according to a new expert position paper.

06/10/2017

US FDA has issued an another guidance on statistical approaches to evaluating similarity for biosimilars this week.

03/10/2017

New acquisition for that say "there is an increased demand for clinical-stage mammalian cell culture-based ".

Lonza will buy Shire’s manufacturing facility in Hayward, California to cater for demand for mammalian cell culture-based drug production.

29/08/2017

The number of approved continues to grow!

A biosimilar version of AbbVie Inc's blockbuster arthritis drug Humira, produced by a joint venture of Biogen Inc and Samsung Biologics, was approved by European Union regulators, the partners said on Thursday.